2020
DOI: 10.1016/j.arteri.2019.10.006
|View full text |Cite
|
Sign up to set email alerts
|

Tejido adiposo epicárdico: un marcador de riesgo cardiovascular a evaluar en la enfermedad renal crónica

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 50 publications
0
2
0
Order By: Relevance
“…Recognition of the adipocyte as a cell type with complex functioning including endocrine, paracrine and autocrine capacity has aroused research interest in disciplines such as nephrology, cardiology, and endocrinology, and it has become a fertile ground for scientific debate. Its wide heterogeneity of location, functions, proteomics, and metabolomics ( 1 ) are particularly important in adiposity, where changes in function and volume are associated with increased cardiorenal and metabolic risk ( Figure 1 ).…”
Section: Organ-specific Fat As Causative Factor Of Cardiorenal Diseasementioning
confidence: 99%
See 1 more Smart Citation
“…Recognition of the adipocyte as a cell type with complex functioning including endocrine, paracrine and autocrine capacity has aroused research interest in disciplines such as nephrology, cardiology, and endocrinology, and it has become a fertile ground for scientific debate. Its wide heterogeneity of location, functions, proteomics, and metabolomics ( 1 ) are particularly important in adiposity, where changes in function and volume are associated with increased cardiorenal and metabolic risk ( Figure 1 ).…”
Section: Organ-specific Fat As Causative Factor Of Cardiorenal Diseasementioning
confidence: 99%
“…Interest in the potential impact of organ-specific adipose tissue on cardiac and renal pathophysiology is growing, and it is clinically important to determine the mechanisms by which fat compartments around the heart and kidneys influence cardiovascular disease (CVD) in both general and high-risk populations ( 1 , 2 ). In these sense, epicardial fat (EF) and perirenal fat (PF) have been associated with adverse outcomes in chronic kidney disease (CKD) patients ( 3 5 ).…”
Section: Introductionmentioning
confidence: 99%